RIPE-KG · Version 1.1.0 · Resource
ripekg:work/RIPEW6F2DA245AB265787
https://w3id.org/ripe/ripe-kg/work/RIPEW6F2DA245AB265787
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1016%2Fj.hsr.2025.100229Effect of sodium-glucose cotransporter-2 inhibitor on metabolic syndrome in people with prediabetes and obesity: A systematic review and meta-analysis |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW6F2DA245AB265787Dapagliflozin once-daily and exenatide once-weekly dual therapy: a 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes |
ripekg:work/RIPEW6F2DA245AB265787Dapagliflozin once-daily and exenatide once-weekly dual therapy: a 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes |
dcterms:title |
Dapagliflozin once-daily and exenatide once-weekly dual therapy: a 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes |
ripekg:work/RIPEW6F2DA245AB265787Dapagliflozin once-daily and exenatide once-weekly dual therapy: a 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes |
rdf:type |
node1 |
ripekg:work/RIPEW6F2DA245AB265787Dapagliflozin once-daily and exenatide once-weekly dual therapy: a 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/RIPEW6F2DA245AB265787Dapagliflozin once-daily and exenatide once-weekly dual therapy: a 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes |
rdf:type |
rdfs:Resource |
ripekg:work/RIPEW6F2DA245AB265787Dapagliflozin once-daily and exenatide once-weekly dual therapy: a 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes |
rdf:type |
owl:Thing |
ripekg:work/RIPEW6F2DA245AB265787Dapagliflozin once-daily and exenatide once-weekly dual therapy: a 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes |
rdf:type |
prov:Entity |
ripekg:work/RIPEW6F2DA245AB265787Dapagliflozin once-daily and exenatide once-weekly dual therapy: a 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes |
rdf:type |
ripe:WorkWork |